Vivo Opportunity reports USD 32,319 purchase of InMed common shares
INM•Vivo Opportunity reports open-market purchases
Vivo Opportunity disclosed open-market purchases of InMed Pharmaceuticals common shares at USD 1.55.
- Vivo Opportunity Fund Holdings reported beneficial ownership rising to 743,057 shares.
- Vivo Opportunity Cayman Fund reported beneficial ownership rising to 75,019 shares.
